Dixon Kaufman, MD, PhD, FACS

Professor

  • Ray D. Owen Professor, Division of Transplantation
  • Director, UW Health Transplant Center

kaufman@surgery.wisc.edu
(608) 265-6471

Clinical Science Center
600 Highland Avenue
Madison WI 53792

Education

  • MD, University of Minnesota
  • NIH National Research Service Award
  • Surgery Internship and Residency, University of Minnesota
  • Transplantation Fellowship, University of Minnesota
  • PhD, University of Minnesota

Honors

Castle Connolly America’s Top Doctors Surgery

Best Doctors in America Award Surgery, Transplantation

Madison Magazine Top Docs 2014 Award Surgery, Transplantation

Avant-Garde Health General Surgery Research All-Stars (2024)

Dr. Kaufman is involved with the following professional societies:

  • American Surgical Association
  • American Society of Transplant Surgeons
  • Association for Academic Surgery
  • Fellow, American College of Surgeons
  • Cell Transplant Society, Founding Member
  • Central Surgical Association
  • International Pancreas and Islet Association, Founding Member
  • Society of University Surgeons
  • The Surgical Biology Club I
  • Transplantation Society
Leadership Roles in Transplantation

Dr. Kaufman has held leadership positions in many facets of the transplant field. He has been very active with the American Society of Transplant Surgeons (ASTS) and has served as Chair of the Education Committee, was the Executive Program Committee Chair for the American Transplant Congress, served on the Council of the ASTS, and was ASTS President. Dr. Kaufman is also very active with the United Network for Organ Sharing (UNOS). He was past Chair of the Pancreas/Islet Transplant Committee, served on the MPSC Committee, served as Councilor of UNOS Region 7, and was a member of the Executive Board. Dr. Kaufman has also been associate editor for the American Journal of Transplantation, Transplantation Journal, and Clinical Transplantation Journal.

Clinical Specialties

Dr. Kaufman is certified by the American Board of Surgery in General Surgery. Dr Kaufman’s clinical focus has been on kidney, pancreas, and islet transplantation. He was the first pancreas transplant surgeon in North America to conduct and publish studies regarding steroid-free immunosuppression in pancreas transplantation, and the first to describe the use of alemtuzumab in pancreas transplants.

Research Interests

Dr. Kaufman’s experimental clinical research has focused on immunosuppression minimization in kidney transplant recipients, and human clinical trials of islet transplantation. His basic research efforts have focused on development of a tolerance induction protocol in large animals. It is supported by an NIH UO-1 award as part of the Non-human Primate Tolerance Study Group Consortium.

Recent Publications

  • Simultaneous en bloc kidney and pancreas transplantation from pediatric donors: Selection, surgical strategy, management, and outcomes.
    Tamburrini R, Yang CY, Philip JL, Neidlinger NA, Kaufman DB, Odorico JS
    Am J Transplant 2024 Nov 19;
    [PubMed ID: 39566660]

  • Risk Factors for Early Post-transplant Weight Changes Among Simultaneous Pancreas-kidney Recipients and Impact on Outcomes.
    Parajuli S, Tamburrini R, Aziz F, Dodin B, Astor BC, Mandelbrot D, Kaufman D, Odorico J
    Transplant Direct 2024 Nov; 10(11): e1720
    [PubMed ID: 39440200]

  • Simultaneous Pancreas-Kidney Transplant Outcomes Stratified by Autoantibodies Status and Pretransplant Fasting C-peptide.
    Parajuli S, Tamburrini R, Aziz F, Dodin B, Astor BC, Mandelbrot D, Kaufman D, Odorico J
    Transplant Direct 2024 Nov; 10(11): e1721
    [PubMed ID: 39399059]

  • Analysis of Rejection, Infection and Surgical Outcomes in Type I Versus Type II Diabetic Recipients After Simultaneous Pancreas-Kidney Transplantation.
    Martinez EJ, Pham PH, Wang JF, Stalter LN, Welch BM, Leverson G, Marka N, Al-Qaoud T, Mandelbrot D, Parajuli S, Sollinger HW, Kaufman DB, Redfield RR, Odorico JS
    Transpl Int 2024; 37: 13087
    [PubMed ID: 39364120]

  • Immunosuppression withdrawal in living-donor renal transplant recipients following induction with antithymocyte globulin and rituximab: Results of a prospective clinical trial.
    Markmann JF, Burrell BE, Bromberg JS, Hartono C, Kaufman DB, Possselt AM, Naji A, Bridges ND, Breeden C, Kanaparthi S, Pardo J, Kopetskie H, Mason K, Lim N, Chandran S
    Am J Transplant 2024 Jul; 24(7): 1193-1204
    [PubMed ID: 38467375]

All Publications on PubMed